These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3899812)

  • 1. Insulin-mediated glucose uptake in nondialyzed and dialyzed uremic insulin-dependent diabetic subjects.
    Schmitz O
    Diabetes; 1985 Nov; 34(11):1152-9. PubMed ID: 3899812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique.
    Schmitz O; Alberti KG; Christensen NJ; Hasling C; Hjøllund E; Beck-Nielsen H; Orskov H
    Metabolism; 1985 May; 34(5):465-73. PubMed ID: 3887103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of hyperglycemia on glucose uptake and hepatic glucose production in non-dialyzed uremic patients.
    Schmitz O; Arnfred J; Orskov L; Nielsen OH; Orskov H; Posborg V
    Clin Nephrol; 1988 Jul; 30(1):27-34. PubMed ID: 2905213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose metabolism in non-diabetic and insulin-dependent diabetic subjects with end-stage renal failure.
    Schmitz O
    Dan Med Bull; 1991 Feb; 38(1):36-52. PubMed ID: 2026051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the splanchnic tissues in the pathogenesis of altered carbohydrate metabolism in patients with chronic renal failure.
    Capaldo B; Cianciaruso B; Napoli R; Andreucci V; Kopple JD; Saccà L
    J Clin Endocrinol Metab; 1990 Jan; 70(1):127-33. PubMed ID: 2403570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of tissue sensitivity to insulin in uraemic patients on long-term haemodialysis therapy.
    Schmitz O; Hjøllund E; Alberti KG; Orskov H; Beck-Nielsen H
    Diabetes Res; 1985 Mar; 2(2):57-63. PubMed ID: 4042532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
    Schmitz O
    Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-mediated glucose disposal in type I diabetes: evidence for insulin resistance.
    Del Prato S; Nosadini R; Tiengo A; Tessari P; Avogaro A; Trevisan R; Valerio A; Muggeo M; Cobelli C; Toffolo G
    J Clin Endocrinol Metab; 1983 Nov; 57(5):904-10. PubMed ID: 6352727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired insulin-stimulated nonoxidative glucose metabolism in pancreas-kidney transplant recipients. Dose-response effects of insulin on glucose turnover.
    Christiansen E; Vestergaard H; Tibell A; Hother-Nielsen O; Holst JJ; Pedersen O; Madsbad S
    Diabetes; 1996 Sep; 45(9):1267-75. PubMed ID: 8772733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site of insulin resistance in type 1 diabetes: insulin-mediated glucose disposal in vivo in relation to insulin binding and action in adipocytes in vitro.
    Yki-Järvinen H; Taskinen MR; Kiviluoto T; Hilden H; Helve E; Koivisto VA; Nikkilä EA
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1183-92. PubMed ID: 6490795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients.
    Luzi L; Groop LC; Perseghin G; Taskinen MR; Hilden H; Bianchi E; Terruzzi I; Dodesini AR; Di Carlo V; Pozza G
    Diabetes; 1996 Mar; 45(3):354-60. PubMed ID: 8593942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of feedback inhibition of insulin secretion in denervated human pancreas.
    Luzi L; Battezzati A; Perseghin G; Bianchi E; Vergani S; Secchi A; La Rocca E; Staudacher C; Spotti D; Ferrari G
    Diabetes; 1992 Dec; 41(12):1632-9. PubMed ID: 1359986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in uremia.
    DeFronzo RA; Alvestrand A; Smith D; Hendler R; Hendler E; Wahren J
    J Clin Invest; 1981 Feb; 67(2):563-8. PubMed ID: 7007440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance.
    Alvestrand A; Mujagic M; Wajngot A; Efendic S
    Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of insulin-mediated and glucose-mediated glucose disposal in patients with insulin-dependent diabetes mellitus and in nondiabetic subjects.
    Hansen IL; Cryer PE; Rizza RA
    Diabetes; 1985 Aug; 34(8):751-5. PubMed ID: 3894118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of insulin on growth hormone-induced metabolic derangements in diabetes.
    Press M; Tamborlane WV; Sherwin RS
    Metabolism; 1986 Oct; 35(10):956-9. PubMed ID: 3531761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic response to the euglycemic insulin clamp in type I diabetes and normal humans.
    Zuniga-Guajardo S; Zinman B
    Metabolism; 1985 Oct; 34(10):926-30. PubMed ID: 3900631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.